Prof. Solange Peters, MD, PhD / David Harpole, MD - Perioperative Immunotherapy: A Multidisciplinary Blueprint for Optimizing Outcomes in Resectable NSCLC

episode

CME in Minutes: Education in Oncology & Hematology not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

5 On It & Tim Jenkins breaks down Bears tape (Hour 3) 39 min · 22 Sep 2026 · Rahimi & Grote Show

Patrick Mannelly talks Bears' loss & Ian Happ talks Cubs' outlook (Hour 2) 44 min · 22 Sep 2026 · Rahimi & Grote Show

Trump's 29% disaster grows as he's in love with Mamdani 1h 12m · 22 Sep 2026 · The David Pakman Show

5 On It: Is the idea of Caleb Williams starting against the Eagles conceivable to you? 16 min · 22 Sep 2026 · Rahimi & Grote Show

#494 — A Coin Toss for the Future 26 min · 22 Sep 2026 · Making Sense with Sam Harris

Deebo & Joe - Part 1: Rams beat Giants + Todd Monken's WEIRD Deshaun Watson comments 51 min · 22 Sep 2026 · Club Shay Shay

Report any issue

Source

Recorded08 Dec 2025

Publisherc.answersincme.com ↗

Handlerec:14387514

Show notes

Please visit answersincme.com/860/97150451-replay1 to participate, download slides and supporting materials, complete the post test, and get a certificate. In this activity, experts in non–small-cell lung cancer (NSCLC) discuss case-based strategies for integrating perioperative immunotherapy in resectable NSCLC. Upon completion of this activity, participants should be better able to: Review the implications of the latest evidence evaluating immunotherapy (IO)-based regimens in resectable and unresectable early-stage non-small cell lung cancer (NSCLC); and Outline multidisciplinary approaches to optimize perioperative and consolidation IO-based treatment strategies in patients with early-stage NSCLC.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in